Darifenacin HydrobromideExtended-Release (Par Pharmaceutical)
Welcome to the PulseAid listing for the Darifenacin Hydrobromide drug offered from Par Pharmaceutical. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical |
NON-PROPRIETARY NAME: | Darifenacin Hydrobromide |
SUBSTANCE NAME: | DARIFENACIN HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-03-15 |
END MARKETING DATE: | 0000-00-00 |
Darifenacin Hydrobromide Extended-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Darifenacin Hydrobromide Extended-Release from Par Pharmaceutical |
LABELER NAME: | Par Pharmaceutical |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15(mg/1) |
START MARKETING DATE: | 2016-03-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10370-171_74921ebb-c5e8-4ae3-9ef5-33c15d6522ac |
PRODUCT NDC: | 10370-171 |
APPLICATION NUMBER: | ANDA091190 |
Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: